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Introduction
Radiation-incuded sarcoma (RIS) is a well known complication 
following radiation therapy. The incidence of radiation-induced 
sarcoma in the head and neck region is rare. The incidence of RIS in 
post-irradiated bone is reported to be in the range of 0.03% to 0.8% [1-
5]. There are also large variations in reported latency period between 
completion of radiotherapy to the development of the sarcoma. This 
can be as short as three years and as long as five decades [5-7].
Treatment of radiation-induced sarcomas may include surgical 
resection, chemotherapy, further irradiation (external beam or 
brachytherapy), or a combination of the above. However, treatment of 
these tumours in the head and neck region, causes great morbidity to 
the patient as vital functional organs may need to be sacrificed and the 
patient is left disfigured.
Current literature reports a poor prognosis for patients with post-
irradiation sarcoma. Wei-wei et al. [4] reported 60% and 24% for one 
and two year survival respectively in a group of patients developing 
osteosarcoma after radiotherapy for nasopharyngeal carcinoma. The 
role of surgery in the treatment of patients with radiation-induced 
sarcoma is still unclear.
Method
A retrospective review was performed on patients diagnosed to 
have radiation-induced sarcoma in the head and neck region, over a 
period 1999-2010. The patients were treated at Queen Mary Hospital, 
a tertiary referral centre and also university teaching hospital in Hong 
Kong. Patients included were those fulfilling the diagnostic criteria set 
out by Cahan in 1948 [8]: 1) The sarcoma arises in an irradiated area, 2) 
There is a relatively long asymptomatic period, 3) There is histological 
proof of the sarcoma and 4) The sarcoma is histologically distinct from 
the original condition. Primary sarcomas arising de novo in the head 
and neck region were excluded.
Data collected included age, gender, latency period from 
completion of radiotherapy to development of sarcoma, site of 
sarcoma, symptoms, histology of sarcoma, treatment given, pathology 
and the survival period.
Statistical analysis was performed using the SPSS package v16.0 
(Table 1).
Results
Patient demographics
A total of 19 patients fitting the criteria were included, eleven 
male and eight female. Eighteen of the patients received radiotherapy 
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Abstract
Introduction: Radiation-induced sarcoma (RIS) is a well-known complication of radiotherapy. It is an aggressive 
tumour and the prognosis is often poor, despite radical treatment. We aim to investigate the role of surgery in the 
treatment of patients with RIS of the head and neck region.
Method: We conducted a retrospective review of records of patients whom were treated for radiation-induced 
sarcoma at Queen Mary Hospital, Hong Kong, between the period 1999 to 2010. Data collected included patient age, 
gender, latency period for the development of RIS, site of RIS, symptoms, treatment given, pathology and survival.
Results: Nineteen patients were included, (M=11, F=8). Eighteen received radiotherapy for treatment of primary 
nasopharyngeal carcinoma. One received radiotherapy for carcinoma of the parotid. The medial latency period for 
the development of sarcoma was 11.1 years (range 5.3-25.1). The most common site for development of RIS was 
the neck (n=8), followed by the oropharynx/oral cavity (n=4), nasopharynx (n=3) nasal cavity (n=2), maxilla (n=1) 
and mandible (n=1). The most common histology was undifferentiated sarcoma (n=6). Nine patients underwent 
surgical resection of the RIS with curative intent, three and six patients achieved R0 and R1 resection respectively. 
Chemotherapy was used in eleven instances after surgery. Radiotherapy was used in seven instances, three 
through brachytherapy, four through external beam irradiation. Overall medial survival from diagnosis of RIS was 
1.74 years (95% CI 0.60-2.87), which improves to 2.47 years (95% CI 0.97-3.97) when only calculating those whom 
surgery was performed.
Conclusions: Patients suffering from radiation-induced sarcomas have a poor prognosis, in keeping with 
existing literature. Treatment is mainly by surgery aiming at resection with a curative intent. If curative resection is 
impossible, surgery may still have a role in palliating the patients’ symptoms such as bleeding, fungation, or pain.
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for nasopharyngeal carcinoma. The remaining patient received 
radiotherapy for carcinoma of the parotid gland. The median age was 
51 years old (range 36-83). The median latency period from the last 
radiotherapy to presentation of sarcoma was 11.1 years (range 5.3-25.1 
years).
Treatment
Of the 19 patients, nine (47%) received surgical resection with 
curative intent. Eight patients (42%) received palliative treatment, 
including four having non-surgical treatment because of unresectable 
disease and four having palliative surgery. Of those having palliative 
surgery, two had debulking surgery and the remaining two had 
macroscopic tumour left behind intraoperatively (Table 2). There were 
a total of thirteen surgeries. One patient refused surgery and another 
one died of unrelated causes. None of the patients presented with 
distant metastases.
The surgeries performed included radical neck dissection 
(n=5), maxillectomy (n=3), maxillary swing nasopharyngectomy 
(n=1), mandibulectomy (n=1), endoscopic assisted cranionasal 
resection (n=1), debulking surgery (n=2). Nine patients required 
flap reconstruction of the resulting defect. These included the 
fasciocutaneous deltopectoral flap (n=3), free anterolateral thigh flap 
(n=3), pectoralis major myocutaneous flap (n=2), and free fibular 
osteocutaneous flap (n=1). Two patients developed local recurrence of 
the sarcoma which further wide local excision and reconstruction was 
performed. The operations performed are detailed in Table 3.
Chemotherapy was used in eleven instances, which eight of them 
were of palliative intent. Radiotherapy was used in seven instances, 
three through brachytherapy, four through external beam irradiation. 
Three of the four patients receiving external beam radiotherapy were 
of palliative intent.
Tumour clearance
Nine of the thirteen patients receiving resection achieved 
macroscopic tumour clearance. Six of these nine patients were found 
to have microscopically involved resection margins. Three patients 
achieved R0 clearance.
Histology
The most common histological type of radiation-induced 
sarcoma was of the undifferentiated type (n=6). This was followed 
by osteosarcoma and rhabdomyosarcoma (n=4 each), pleomorphic 
sarcoma (n=2), angiosarcoma (n=1), leiomyosarcoma (n=1) and 
malignant fibrohistiosarcoma (n=1).
Local recurrence and distant metastasis
Two patients who initially had R0 resection of the neck tumour 
developed local recurrence, necessitating further wide resection. These 
two patients currently have no evidence of tumour recurrence. Two 
patients, who initially achieved R1 resection, later developed lung 
metastasis without local recurrence and subsequently passed away. 
Two patients recently developed to have local recurrences at the time 
of analysis pending further workup and treatment.
Survival
Overall median survival from diagnosis of sarcoma was 1.74 years 
(95% CI 0.60-2.87). For the thirteen patients who underwent surgical 
resection, the median survival was 2.47 years (95% CI 0.97-3.97). For 
those who had no surgery, median survival was 0.82 years (95% CI 
0.35-1.29).
Symptoms and morbidities 
Five patients (26%) complained of recurrent tumour bleeding and 
fungation.One patient them died from a carotid blow-out secondary 
to direct tumour invasion. Four patients had good palliation of 
symptoms of bleeding and fungation after the tumour was surgically 
resected with flap coverage, even though clear margins could not be 
achieved. Three patients (16%) had intractable pain despite analgesics. 
In one patient the tumour invading into the brachial plexus was 
excised macroscopically for palliation, followed by flap coverage and 
brachytherapy. There was good palliation of her pain for more than 
n=19 Proportion
Latency Period
 >20 years 3 16%
 10-20 years 11 58%
 5-9 years 5 26%
 1-4 years 0 0%
Site
 Neck 8 42%
 Oropharynx / Oral cavity 4 21%
 Nasopharynx 3 16%
 Nasal Cavity 2 11%
 Maxilla 1 5.3%
 Mandible 1 5.3%
Histology
 Undifferentiated 6 32%
 Osteosarcoma 4 21%
 Rhabdomyosarcoma 4 21%
 Pleomorphic sarcoma 2 11%
 Angiosarcoma 1 5.3%
 Leiomyosarcoma 1 5.3%
 Malignant fibrohistiosarcoma 1 5.3%
Table 1: Tumour characteristics.
Treatment
 Surgical resection 13 68%
 R2 Resection 4 21%
 R1 Resection 6 32%
 R0 Resection 3 16%
 Adjuvant External RT 1 *
 Palliative External RT 3 *
 Brachytherapy 3 *
 Adjuvant chemotherapy 3 *
 Palliative chemotherapy 8 *
Outcome
Died of disease (inclusive of local disease 
progression, local recurrence, 
distant metastasis)
10 53%
Died of complications of chemotherapy 2 11%
Died of unrelated causes 2 11%
Alive without disease 3 16%
Alive with local recurrence 2 11%
* Percentages not calculated as these numbers indicated occurrences of each 
therapeutic method.
Table 2: Treatment and outcome of patients.
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a year before the sarcoma rapidly recurred. Four patients (21%) had 
symptoms of dysphagia and/or aspiration and required nutrition via 
a nasogastric tube. Two patients (11%) had airway problems requiring 
a tracheostomy. Two patients (11%) died of neutropenic sepsis during 
the course of chemotherapy.
Discussion
Radiation-induced sarcoma of the head and neck region, although 
a well known complication of the treatment itself, remains a rare 
diagnosis of poor prognosis [9,10]. The incidence of RIS increased 
with patient’s age [2,11]. Survival of these patients is much poorer 
than patients having sarcoma of the extremities [3,12]. The reported 
overall 5-year survival is in the range of 10-30% [3,13-15]. In our group 
of patients, the median latency period of 11.1 years is comparable to 
the current available literature. This highlights the need for lifelong 
follow-up and surveillance of the cancer patient for any ill-effects from 
previous treatment, even when the patient is disease free from the 
primary tumour.
In our series eight patients received palliative treatment, which is 
42% of the series. This is possibly the result of an aggressive tumour 
located in a body region that contains numerous vital structures and 
functional organs. Reasons for adopting palliative treatment might be 
due to encasement of major vessels such as the internal carotid artery, 
tumour too locally extensive at presentation. Where the patient was 
initially treated at a regional hospital, lack of expertise and awareness 
in reconstructive surgery options might lead to premature surrender 
to medical futility. Patients may also refuse surgery out of concern of 
significant facial disfigurement after radical surgery in the head and 
neck region.
# Sex Age
Latency 
Period 
(years)
Size and Site of 
Tumour Operation
Recon- 
struction Clearance
Chemotherapy / 
Radiotherapy
Outcome 
(at time of analysis)
Survival from 
diagnosis 
(Years)
1 F 46 10.0 Right neck Debulking DP Flap R2
Brachytherapy 
and 
palliative 
chemotherapy
Disease progression, 
died 5.42
2 F 40 9.8 Left nasopharynx (Unresectable) - - Palliative chemotherapy
Disease progression, 
died 0.83
3 M 56 20.0
1) Left neck
2) Local recurrence 
 (5 years interval)
1) RND
2) Wide local excision, 
manubrial resection
1) DP Flap
2) PM Flap
1) R0
2) R0 2) Brachytherapy Alive without disease
Alive
4 F 49 18.2 Left nasal cavity Endoscopic cranionasal resection - R1
Palliative 
chemotherapy Local recurrence, died 2.5
5 F 48 23.3 Right upper alveolus (Refused) - - -
Disease progression, 
died 1.92
6 M 36 11.0 Nasopharynx Maxillary swing nasopharyngectomy - R2
Palliative 
chemotherapy
Died of chemotherapy 
complication 0.42
7 F 64 25.2 Right oropharynx (Unresectable) - - Palliative chemotherapy
Disease progression, 
died 1.75
8 F 52 5.3 Right nasal cavity Endoscopic debulking R2 Palliative chemotherapy
Died of chemotherapy 
complication 0.92
9 M 48 9.3 Right mandible Segmental mandibulectomy
Reconstruction 
plate + PM 
Flap
R1 - Lung metastases, died 1.58
10 M 48 22.3 Left maxilla Maxillectomy ALT flap R2 Palliative chemoirradiation
Disease progression, 
died 1.83
11 F 83 20.0 Right neck Nil - - - Died of unrelated cause 0.25
12 M 55 10.3 Left neck RND - R0 - Alive without disease Alive
13 M 51 10.2 Right neck RND PM Flap R1 - Died of unrelated cause 0.92
14 F 55 7.0
1) Right neck
2) Local recurrence 
(1 year interval)
1) RND
2) Wide local excision 2) PM Flap
R0
1) Adjuvant 
chemotherapy
2) Brachytherapy Alive without disease
Alive
15 M 54 12.2 Right neck (Unresectable) - -
Palliative 
chemotherapy 
and haemostatic 
RT
Disease progression, 
died 0.75
16 M 69 7.7 Right neck RND DP Flap R1 - Lung metastases, died 0.75
17 M 47 11.2 Nasopharynx (Unresectable) - - Haemostatic RT Disease progression, died 0.75
18 M 47 12.3 Oral cavity Maxillectomy ALT flap R1 Adjuvant chemotherapy Local recurrence Alive
19 M 63 15.0
1) Alveolus
2) Skull base 
recurrence
1) Maxillectomy
2) Craniofacial resection
ALT flap
1) R1
2) R1
1) Adjuvant RT
2) Adjuvant 
chemotherapy
Local recurrence Alive
Table 3: Detailed information on patients’ presenting symptoms, treatment offered, outcome and survival.
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Nine patients out of the thirteen undergoing surgery (69%) in our 
series received flap reconstruction of the resulting defect after tumour 
resection. When the radiation-induced sarcoma arises in the neck, 
we have a low threshold to excise the overlying skin together with 
the tumour so as to achieve better margins. When brachytherapy is 
contemplated, coverage preferably is performed using a reliable and 
robust flap such as the pectoralis major myocutaneous flap containing 
a good bulk of muscle to protect the carotid artery. This theoretically 
reduces the chance of carotid blow-out as the artery is likely to be laid 
bare after surgery. Reconstruction of other portions of the facial soft 
and bony tissues would follow existing reconstructive principles.
Chemotherapy is often applied to patients after surgical resection. 
Literature on usage of chemotherapy in radiation-induced sarcomas 
has been limited, and most reports spawn from treatment of primary 
sarcoma, especially osteogenic sarcoma in children and adults [12,16]. 
It is uncertain whether these regimens can be directly applied to 
radiation-induced sarcomas of the head and neck region and no large 
scale studies have been performed. Moreover, chemotherapy is not 
without its own complications. Two of our died from neutropenic 
sepsis while on chemotherapy.
The median survival was 2.47 years and 0.82 years respectively 
in those who had surgical resection versus those who had not. Given 
our small sample size, survival curve generation and further statistical 
testing was not performed. Our data seems to show that in a highly 
selected group of patients where R0 or R1 resection can be achieved, 
there may be a survival benefit. Further studies should be undertaken 
to clarify this.. In those patients where surgery was not curative, 
achieving gross tumour clearance may allow the patient to be palliated 
of symptoms of tumour bleeding, fungation and pain.
Of the three patients achieving R0 resection, two eventually 
developed local recurrences. This highlights the dilemma in treating 
radiation-induced sarcomas in the head and neck region where good 
margins are difficult if not impossible. Patients after treatment must 
also be followed-up regularly to pick up local recurrences promptly. 
It was fortunate that in both these cases, the recurrence was picked up 
early such that a second R0 resection could be made. Nevertheless, one 
patient required manubrial resection to achieve this.
Conclusions
Patients suffering from radiation-induced sarcomas have a poor 
prognosis, in keeping with existing literature. The role of surgery is 
to resect with a curative intent when possible. If curative resection 
is impossible, surgery may still have a role in palliating the patients’ 
symptoms such as bleeding, fungation, or pain.
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